For: | Kogure T, Ueno Y, Fukushima K, Nagasaki F, Inoue J, Kakazu E, Matsuda Y, Kido O, Nakagome Y, Kimura O, Obara N, Wakui Y, Iwasaki T, Shimosegawa T. Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment. World J Gastroenterol 2007; 13(32): 4394-4397 [PMID: 17708618 DOI: 10.3748/wjg.v13.i32.4394] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i32/4394.htm |
Number | Citing Articles |
1 |
Tatsuo Kanda, Naoki Matsumoto, Tomotaka Ishii, Shuhei Arima, Shinji Shibuya, Masayuki Honda, Reina Sasaki-Tanaka, Ryota Masuzaki, Shini Kanezawa, Tsukasa Nishizawa, Yasuhiro Gon, Masahiro Ogawa, Hirofumi Kogure. Chronic Hepatitis C: Acute Exacerbation and Alanine Aminotransferase Flare. Viruses 2023; 15(1): 183 doi: 10.3390/v15010183
|
2 |
T. Casanovas, A. Argudo, M.C. Peña-Cala. Effectiveness and Safety of Everolimus in the Treatment of Autoimmune Hepatitis Related to Anti-Hepatitis C Virus Therapy After Liver Transplant: Three Case Reports. Transplantation Proceedings 2011; 43(6): 2233 doi: 10.1016/j.transproceed.2011.05.028
|
3 |
Kay Washington, Michael P. Manns. Macsween's Pathology of the Liver. 2018; : 491 doi: 10.1016/B978-0-7020-6697-9.00008-X
|
4 |
AbdulrahmanA Aljumah, Badr Al Jarallah, Ali Albenmousa, Abdullah Al Khathlan, Adnan Al Zanbagi, Mohammed Al Quaiz, Bandar Al-Judaibi, Khalid Nabrawi, Waleed Al Hamoudi, Mohammed Alghamdi, Hind Fallatah. The Saudi association for the study of liver diseases and transplantation clinical practice guidelines for management of autoimmune hepatitis. Saudi Journal of Gastroenterology 2018; 24(7): 1 doi: 10.4103/sjg.SJG_159_18
|
5 |
Raul S. Gonzalez, Kay Washington, Ansgar W. Lohse. MacSween's Pathology of the Liver. 2024; : 527 doi: 10.1016/B978-0-7020-8228-3.00008-9
|
6 |
Satoshi Oeda, Toshihiko Mizuta, Hiroshi Isoda, Takuya Kuwashiro, Noriko Oza, Shinji Iwane, Hirokazu Takahashi, Yasunori Kawaguchi, Yuichiro Eguchi, Shuji Toda, Iwata Ozaki, Keizo Anzai, Kazuma Fujimoto. Efficacy of pegylated interferon plus ribavirin in combination with corticosteroid for two cases of combined hepatitis C and autoimmune hepatitis. Clinical Journal of Gastroenterology 2012; 5(2): 141 doi: 10.1007/s12328-012-0295-4
|
7 |
Ashish Kumar Jha, Sandeep Nijhawan, Ramesh Roop Rai, Subhash Nepalia, Pankaj Jain, Arya Suchismita. Etiology, clinical profile, and inhospital mortality of acute-on-chronic liver failure: a prospective study. Indian Journal of Gastroenterology 2013; 32(2): 108 doi: 10.1007/s12664-012-0295-9
|
8 |
Kotaro Matsumoto, Kentaro Kikuchi, Yuta Namura, Ayako Watanabe, Hiromichi Tsunashima, Shinpei Doi. Histological improvement in chronic hepatitis C-autoimmune hepatitis overlap syndrome by glecaprevir and pibrentasvir. Clinical Journal of Gastroenterology 2023; 16(4): 572 doi: 10.1007/s12328-023-01809-7
|
9 |
Danya Rosen, Jaime Chu, Raffaella Morotti, Daniela Levanon, Samantha Rose, Samantha Lee, Ronen Arnon. Hepatitis C Virus‐Autoimmune Hepatitis Overlap Syndrome in an Adolescent. Journal of Pediatric Gastroenterology and Nutrition 2015; 61(2) doi: 10.1097/MPG.0000000000000257
|
10 |
Teru Kumagi, Khalid Alswat, Gideon M. Hirschfield, Jenny Heathcote. New insights into autoimmune liver diseases. Hepatology Research 2008; 38(8): 745 doi: 10.1111/j.1872-034X.2008.00366.x
|
11 |
Richard Parker, Ye Htun Oo, David H. Adams. Management of patients with difficult autoimmune hepatitis. Therapeutic Advances in Gastroenterology 2012; 5(6): 421 doi: 10.1177/1756283X12450251
|
12 |
Benjamin Morlet, Malak Abou Taam, Voa Ratsimbazafy. Les cytokines du système immunitaire et leurs antagonistes en thérapeutique. Actualités Pharmaceutiques Hospitalières 2009; 5(20): 36 doi: 10.1016/S1769-7344(09)70207-0
|
13 |
Nazia Selzner, Maha Guindi, Eberhard L. Renner, Marina Berenguer. Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients. Journal of Hepatology 2011; 55(1): 207 doi: 10.1016/j.jhep.2010.11.012
|
14 |
M. Kay Washington, Michael P. Manns. MacSween's Pathology of the Liver. 2012; : 467 doi: 10.1016/B978-0-7020-3398-8.00009-X
|
15 |
Qing Mao, Hui-Yan Zhang, Jian-Ping You, Xu-Qing Zhang. Severe acute exacerbation of chronic hepatitis B during pegylated interferon treatment and early intervention with corticosteroid. Virology Journal 2012; 9(1) doi: 10.1186/1743-422X-9-136
|
16 |
Silvia Ferri, Luigi Muratori, Chiara Quarneti, Paolo Muratori, Rita Menichella, Georgios Pappas, Alessandro Granito, Giorgio Ballardini, Francesco B. Bianchi, Marco Lenzi. Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C. Journal of Hepatology 2009; 50(6): 1093 doi: 10.1016/j.jhep.2009.02.020
|
17 |
Giovanni Covini, Wendy C Carcamo, Elena Bredi, Carlos A von Mühlen, Massimo Colombo, Edward KL Chan. Cytoplasmic Rods and Rings Autoantibodies Developed during Pegylated Interferon and Ribavirin Therapy in Patients with Chronic Hepatitis C. Antiviral Therapy 2012; 17(5): 805 doi: 10.3851/IMP1993
|
18 |
Jen-Jung Pan, Jeffrey S. Crippin. Hepatitis C and Autoimmune Hepatitis: What Gets Treated First?. Current Hepatitis Reports 2010; 9(1): 15 doi: 10.1007/s11901-009-0026-6
|
19 |
Ali Benmousa, Ahmed Helmy, Faisal M Sanai, Zuhal M Ghandour. Autoimmune Hepatitis Induced by Interferon Beta Therapy in a Patient with Multiple Sclerosis: A Case Report. Journal of Pharmacy Technology 2009; 25(6): 374 doi: 10.1177/875512250902500605
|
20 |
Yo‐hei Aoki, Shogo Ohkoshi, Satoshi Yamagiwa, Masahiko Yano, Hiromichi Takahashi, Nobuo Waguri, Kentaro Igarashi, Soh‐ichi Sugitani, Toru Takahashi, Toru Ishikawa, Tomoteru Kamimura, Hiroto Wakabayashi, Toshiaki Watanabe, Yasunobu Matsuda, Minoru Nomoto, Yutaka Aoyagi. Characterization of elevated alanine aminotransferase levels during pegylated‐interferon α‐2b plus ribavirin treatment for chronic hepatitis C. Hepatology Research 2011; 41(2): 118 doi: 10.1111/j.1872-034X.2010.00749.x
|
21 |
David W. Wan, Kristen Marks, Rhonda K. Yantiss, Andrew H. Talal. Autoimmune Hepatitis in the HIV-Infected Patient: A Therapeutic Dilemma. AIDS Patient Care and STDs 2009; 23(6): 407 doi: 10.1089/apc.2008.0149
|
22 |
Farhad Sahebjam, Cristina H Hajdu, Esther Nortey, Samuel H Sigal. Direct acting antiviral therapy is curative for chronic hepatitis C/autoimmune hepatitis overlap syndrome. World Journal of Hepatology 2016; 8(14): 632-636 doi: 10.4254/wjh.v8.i14.632
|
23 |
Bruce A. Luxon. Diagnosis and Treatment of Autoimmune Hepatitis. Gastroenterology Clinics of North America 2008; 37(2): 461 doi: 10.1016/j.gtc.2008.02.002
|
24 |
Fabio Salvatore Macaluso, Nicola Alessi, Daniela Cabibi. Antimitochondrial antibody ‐M2 positive autoimmune hepatitis during standard of care for chronic hepatitis C. Hepatology Research 2012; 42(4): 428 doi: 10.1111/j.1872-034X.2011.00931.x
|